Prenatal diagnosis of hemoglobinopathies involves the study of fetal material from blood, amniocytes, trophoblast coelomatic cells and fetal DNA in maternal circulation. Its first application dates back to the 70s and it involves globin chain synthesis analysis on fetal blood. In the 1980s molecular analysis was introduced as well as amniocentesis and chorionic villi sampling under high-resolution ultrasound imaging. The application of direct sequencing and polymerase chain reactionbased methodologies improved the DNA analysis procedures and reduced the sampling age for invasive prenatal diagnosis from 18 to 16- 11 weeks allowing fetal genotyping within the first trimester of pregnancy. In the last years, fetal material obtained at 7-8 weeks of gestation by coelocentesis and isolation of fetal cells has provided new platforms on which to develop diagnostic capabilities while non-invasive technologies using fetal DNA in maternal circulation are starting to develop.
Prenatal diagnosis of hemoglobinopathies: from fetoscopy to coelocentesis
G. Damiani,M. Vinciguerra,C. Jakil,M. Cannata,F. Cassarà,F. Picciotto,G. Schillaci,V. Cigna,D. Renda,A. Volpes,F. Sammartano,S. Milone,A. Allegra,C. Passarello,F. Leto,A. Giambona
Published 2014 in Thalassemia Reports
ABSTRACT
PUBLICATION RECORD
- Publication year
2014
- Venue
Thalassemia Reports
- Publication date
2014-09-29
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
- No citing papers are available for this paper.
Showing 0-0 of 0 citing papers · Page 1 of 1